These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 12452063

  • 1. [Influence of selective cyclooxygenase-2 inhibitor on proliferation of human gastric cancer cells].
    Li JY, Yu JP, Luo HS, Yu BP, Tian G, Mei Q, Huang JA.
    Ai Zheng; 2002 Jun; 21(6):625-9. PubMed ID: 12452063
    [Abstract] [Full Text] [Related]

  • 2. Synthetic and naturally occurring COX-2 inhibitors suppress proliferation in a human oesophageal adenocarcinoma cell line (OE33) by inducing apoptosis and cell cycle arrest.
    Cheong E, Ivory K, Doleman J, Parker ML, Rhodes M, Johnson IT.
    Carcinogenesis; 2004 Oct; 25(10):1945-52. PubMed ID: 15155531
    [Abstract] [Full Text] [Related]

  • 3. Inhibited proliferation of cyclooxygenase-2 expressing human hepatoma cells by NS-398, a selective COX-2 inhibitor.
    Hu KQ, Yu CH, Mineyama Y, McCracken JD, Hillebrand DJ, Hasan M.
    Int J Oncol; 2003 Apr; 22(4):757-63. PubMed ID: 12632065
    [Abstract] [Full Text] [Related]

  • 4. Direct evidence for a role of cyclooxygenase 2-derived prostaglandin E2 in human head and neck xenograft tumors.
    Zweifel BS, Davis TW, Ornberg RL, Masferrer JL.
    Cancer Res; 2002 Nov 15; 62(22):6706-11. PubMed ID: 12438270
    [Abstract] [Full Text] [Related]

  • 5. [Mechanisms of inhibiting proliferation and inducing apoptosis of human gastric cancer cell line SGC7901 by ursolic acid].
    Zhang YY, Deng T, Hu ZF, Zhang QP, Zhang J, Jiang H.
    Ai Zheng; 2006 Apr 15; 25(4):432-7. PubMed ID: 16613675
    [Abstract] [Full Text] [Related]

  • 6. [Effects of selective cyclooxygenase-2 inhibitor NS-398 on 5-fluorouracil chemotherapy and progression of colon cells: an experimental study].
    Zhang YC, Wang S, Zhang H, Ye YJ, Liang B, Cui ZR.
    Zhonghua Yi Xue Za Zhi; 2004 Apr 02; 84(7):583-6. PubMed ID: 15144595
    [Abstract] [Full Text] [Related]

  • 7. Apoptosis induction and enhancement of cytotoxicity of anticancer drugs by celecoxib, a selective cyclooxygenase-2 inhibitor, in human head and neck carcinoma cell lines.
    Hashitani S, Urade M, Nishimura N, Maeda T, Takaoka K, Noguchi K, Sakurai K.
    Int J Oncol; 2003 Sep 02; 23(3):665-72. PubMed ID: 12888902
    [Abstract] [Full Text] [Related]

  • 8. Induction of apoptosis in rheumatoid synovial fibroblasts by celecoxib, but not by other selective cyclooxygenase 2 inhibitors.
    Kusunoki N, Yamazaki R, Kawai S.
    Arthritis Rheum; 2002 Dec 02; 46(12):3159-67. PubMed ID: 12483719
    [Abstract] [Full Text] [Related]

  • 9. Induction of apoptosis by JTE-522, a specific cyclooxygenase-2 inhibitor, in human gastric cancer cell lines.
    Uefuji K, Ichikura T, Shinomiya N, Mochizuki H.
    Anticancer Res; 2000 Dec 02; 20(6B):4279-84. PubMed ID: 11205258
    [Abstract] [Full Text] [Related]

  • 10. A selective cyclooxygenase-2 inhibitor, NS-398, inhibits cell growth by cell cycle arrest in a human malignant fibrous histiocytoma cell line.
    Yamashita H, Osaki M, Honjo S, Yoshida H, Teshima R, Ito H.
    Anticancer Res; 2003 Dec 02; 23(6C):4671-6. PubMed ID: 14981912
    [Abstract] [Full Text] [Related]

  • 11. Effects of the selective COX-2 inhibitors celecoxib and rofecoxib on human vascular cells.
    Niederberger E, Manderscheid C, Grösch S, Schmidt H, Ehnert C, Geisslinger G.
    Biochem Pharmacol; 2004 Jul 15; 68(2):341-50. PubMed ID: 15194006
    [Abstract] [Full Text] [Related]

  • 12. The cyclooxygenase 2-selective inhibitor NS398 inhibits proliferation of oral carcinoma cell lines by mechanisms dependent and independent of reduced prostaglandin E2 synthesis.
    Minter HA, Eveson JW, Huntley S, Elder DJ, Hague A.
    Clin Cancer Res; 2003 May 15; 9(5):1885-97. PubMed ID: 12738747
    [Abstract] [Full Text] [Related]

  • 13. Nimesulide and indomethacin induce apoptosis in head and neck cancer cells.
    Pelzmann M, Thurnher D, Gedlicka C, Martinek H, Knerer B.
    J Oral Pathol Med; 2004 Nov 15; 33(10):607-13. PubMed ID: 15482327
    [Abstract] [Full Text] [Related]

  • 14. Suppressive effect of selective cyclooxygenase-2 inhibitor on cytokine release in human neutrophils.
    Kimura T, Iwase M, Kondo G, Watanabe H, Ohashi M, Ito D, Nagumo M.
    Int Immunopharmacol; 2003 Oct 15; 3(10-11):1519-28. PubMed ID: 12946449
    [Abstract] [Full Text] [Related]

  • 15. Effects of cyclooxygenase 2 inhibitors on biological traits of nasopharyngeal carcinoma cells.
    Chen PY, Long QC.
    Acta Pharmacol Sin; 2004 Jul 15; 25(7):943-9. PubMed ID: 15210070
    [Abstract] [Full Text] [Related]

  • 16. Cyclooxygenase-2 (COX-2) inhibitors sensitize tumor cells specifically to death receptor-induced apoptosis independently of COX-2 inhibition.
    Totzke G, Schulze-Osthoff K, Jänicke RU.
    Oncogene; 2003 Sep 11; 22(39):8021-30. PubMed ID: 12970750
    [Abstract] [Full Text] [Related]

  • 17. NS-398 inhibits tumor growth and liver metastasis of colon cancer through induction of apoptosis and suppression of the plasminogen activation system in a mouse model.
    Nishikawa M, Stapleton PP, Freeman TA, Gaughan JP, Matsuda T, Daly JM.
    J Am Coll Surg; 2004 Sep 11; 199(3):428-35. PubMed ID: 15325613
    [Abstract] [Full Text] [Related]

  • 18. Specific COX-2 inhibitor, NS-398, suppresses cellular proliferation and induces apoptosis in human hepatocellular carcinoma cells.
    Cheng AS, Chan HL, Leung WK, Wong N, Johnson PJ, Sung JJ.
    Int J Oncol; 2003 Jul 11; 23(1):113-9. PubMed ID: 12792783
    [Abstract] [Full Text] [Related]

  • 19. Cyclooxygenase-2 inhibitor induces apoptosis and enhances cytotoxicity of various anticancer agents in non-small cell lung cancer cell lines.
    Hida T, Kozaki K, Muramatsu H, Masuda A, Shimizu S, Mitsudomi T, Sugiura T, Ogawa M, Takahashi T.
    Clin Cancer Res; 2000 May 11; 6(5):2006-11. PubMed ID: 10815926
    [Abstract] [Full Text] [Related]

  • 20. A selective cyclooxygenase-2 inhibitor, NS398, inhibits cell growth and induces cell cycle arrest in the G2/M phase in human esophageal squamous cell carcinoma cells.
    Kase S, Osaki M, Honjo S, Takeda A, Adachi K, Araki K, Ito H.
    J Exp Clin Cancer Res; 2004 Jun 11; 23(2):301-7. PubMed ID: 15354416
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.